Molecular recognition of lipopolysaccaride by the lantibiotic nisin by Lanne, Alice B.M. et al.
  
 1 
Molecular recognition of lipopolysaccharide by the lantibiotic nisin 1 
 2 
By:  3 
Alice BM Lanne1, Alice Goode1, Charlotte Prattley1, Divya Kumari1, Mette Ryun Drasbek3, Paul 4 
Williams2, Raquel Conde-Álvarez4, Ignacio Moriyón4 & Boyan B. Bonev1* 5 
 6 
 7 
 8 
From: 9 
1 School of Life Sciences, QMC, University of Nottingham, Nottingham NG7 2UH, UK 10 
2 Centre for Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD, UK 11 
3 DuPont Nutrition Biosciences ApS. Edwin Rahrs Vej 38, DK-8220 Brabrand, Denmark 12 
4 Instituto de Salud Tropical, Instituto de Investigación Sanitaria de Navarra, and Departamento de 13 
Microbiología y Parasitología, Universidad de Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain. 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
* Correspondence: boyan.bonev@nottingham.ac.uk   24 
 2 
Abstract 1 
Nisin is a lanthionine antimicrobial effective against diverse Gram-positive bacteria and is used as 2 
a food preservative worldwide. Its action is mediated by pyrophosphate recognition of the 3 
bacterial cell wall receptors lipid II and undecaprenyl pyrophosphate. Nisin/receptor complexes 4 
disrupt cytoplasmic membranes, inhibit cell wall synthesis and dysregulate bacterial cell division. 5 
Gram-negative bacteria are much more tolerant to antimicrobials including nisin.  In contrast to 6 
Gram-positives, Gram-negative bacteria possess an outer membrane, the major constituent of 7 
which is lipopolysaccharide (LPS). This contains surface exposed phosphate and pyrophosphate 8 
groups and hence can be targeted by nisin. Here we describe the impact of LPS on membrane 9 
stability in response to nisin and the molecular interactions occurring between nisin and 10 
membrane-embedded LPS from different Gram-negative bacteria. Dye release from liposomes 11 
shows enhanced susceptibility to nisin in the presence of LPS, particularly rough LPS chemotypes 12 
that lack an O-antigen whereas LPS from microorganisms sharing similar ecological niches with 13 
antimicrobial producers provides only modest enhancement. Increased susceptibility was 14 
observed with LPS from pathogenic Klebsiella pneumoniae compared to LPS from 15 
enteropathogenic Salmonella enterica and gut commensal Escherichia coli. LPS from Brucella 16 
melitensis, an intra-cellular pathogen which is adapted to invade professional and non-17 
professional phagocytes, appears to be refractory to nisin. Molecular complex formation between 18 
nisin and LPS was studied by solid state MAS NMR and revealed complex formation between nisin 19 
and LPS from most organisms investigated except B. melitensis. LPS/nisin complex formation was 20 
confirmed in outer membrane extracts from E. coli.  21 
 22 
  23 
  
 3 
Introduction 1 
 2 
The rise in antimicrobial resistance (AMR) poses a significant global threat to the management of 3 
infectious diseases. Gram-negative pathogens are particularly problematic, as emerging resistance 4 
to last-line drugs has been reported [1] and they constitute all of the entries to the WHO AMR 5 
critical pathogen priority list [2]. In addition to the threat posed by AMR, control of food related 6 
Gram-negative bacteria is an essential component of global food security [3]. A key feature of 7 
Gram-negative bacteria contributing to AMR is the presence of an outer membrane (OM) 8 
permeability barrier  that  protects peptidoglycan and other intracellular targets from antibiotics 9 
and other antimicrobials.    10 
 11 
Bacterial outer membranes are asymmetric protein embedded bilayers with phospholipid inner 12 
leaflets and lipopolysaccharide (LPS) outer leaflets. The OM defines bacterial interactions with the 13 
host and the environment and acts as a selectivity barrier with a key role in molecular uptake [4]. 14 
The OM protects bacteria from environmental noxious molecules including many antibiotics [5] 15 
and modulates susceptibility to cationic antimicrobial peptides [6]. 16 
 17 
LPS molecules commonly contain three regions: a conserved hexa- or hepta-acyl disaccharide, lipid 18 
A, which acts as a hydrophobic anchor to the membrane; a core oligosaccharide, which can be 19 
further subdivided into the conserved inner region and variable outer core; and, a specific O-20 
antigen that varies greatly between species [5]. LPS containing all 3 components confers a 21 
‘smooth’ surface phenotype, while mutants lacking an O-antigen and sometimes parts of the inner 22 
core result in chemotypes that present as rough  bacterial colony phenotypes.  23 
 24 
 4 
LPS shows structural variation between bacterial species with highest degree of similarity within 1 
the lipid A region and species- or serotype-specificity contained in the outer core and O-antigen. 2 
Most lipid A structures contain a (1-6)-linked glucosamine disaccharide backbone, which is 3 
acylated with chains that vary in length and number depending on species and is usually 4 
phosphorylated at positions 1 and 4’ [7] or sometimes carrying pyrophosphorylethanolamine 5 
(Figure 1A) [8]. However, some bacteria present a different lipid A chemotype. For example, one 6 
important and distinctive feature of lipid A in the Brucellae is the presence of a diaminoglucose 7 
backbone carrying very long, mostly 28-carbon chains, hydroxylated at the penultimate methylene 8 
(Figure 1A) (Moreno et al. 1990, Iriarte, Gonzalez et al. 2004) . Such C28 chains have the correct 9 
length and hydrophilic termination to traverse both leaflets of the OM and can enhance bilayer 10 
stability as observed for archaeal membranes containing prenylated lipids.  11 
 12 
Covalently linked to Lipid A, the core region is a short oligosaccharide composed of up to 15 13 
sugars. The core region shows species variation with only one common structural element; 3-14 
Deoxy-D-manno-oct-2-ulosonic acid (KDO), which links the core region to Lipid A [10]. KDO is often 15 
linked to several heptose residues with additional phosphate or sulfate groups but some bacteria 16 
lack core heptose [10–12]. The outer core varies more between species and consists of common 17 
hexose and hexosamine sugars [13].  Recently, we have shown that the outer core from E. coli 18 
rough-type C LPS is both phosphorylated and pyrophosphorylated [8]. The structural composition 19 
of LPS core in Klebsiella pneumoniae [14], Escherichia coli [12] and Brucella melitensis [15,16],  is 20 
shown in Figure 1B.  21 
 22 
The O-antigen displays structural diversity in both sugar composition and connectivity, which 23 
imparts an immunological fingerprint to bacteria. It is an antigenic polysaccharide formed of up to 24 
  
 5 
40 repeating oligosaccharide units, predominantly neutral and basic hexose residues [13]. The O-1 
antigen is the least conserved region of LPS, with over 190 chemotypes in E. coli alone [17]. 2 
 3 
LPS is shed from the OM as endotoxin during cell division and activates the host immune response 4 
through Toll-like receptor 4, TLR4 [18]. LPS-binding protein (LPB) and CD-14-MD-2 are also 5 
involved in receptor activation by LPS [19,20]. Receptor recognition of LPS shows some species 6 
specificity, often correlating with the ecological niche occupied by the species. LPS from some 7 
commensal species possess much weaker receptor binding than some pathogenic species [21]. 8 
Some bacterial pathogens exploit reduced LPS receptor recognition as a method of immune 9 
evasion [22,23].  10 
 11 
As well as TLR4 activation, LPS makes essential receptor-independent interactions with host cell 12 
membranes. We have previously shown that cholesterol in lipid rafts plays an important role in 13 
LPS recognition, with LPS binding at higher affinity within lipid raft models. This has also been 14 
demonstrated in live cell experiments, with a reduction in LPS binding to Jurkat T-lymphocyte 15 
membranes upon cholesterol removal [24]. This receptor-independent binding of LPS to 16 
cholesterol also varies with the ecological niche of species, with the LPS of commensal organisms 17 
showing significantly weaker binding to membranes than that of many pathogens [24].  18 
 19 
Although the OM can be a major obstacle to antibiotic delivery, LPS also presents a specific target 20 
for antimicrobials, which use LPS as receptor to gain entry into bacteria to access peptidoglycan or 21 
other intracellular targets. An example of this is colicin N, which unlike other colicins targets Gram-22 
negative species via molecular recognition of a specific pyrophosphate binding epitope in the LPS 23 
outer-core [8]. An alternate approach is the use of LPS as a direct target for antimicrobial activity. 24 
For example, polymyxin B binds LPS directly via electrostatic interactions and penetrates via a self-25 
 6 
promoted mechanism, resulting in extensive OM damage and inner membrane depolarisation 1 
[25,26]. There are also antimicrobials with high LPS binding affinity that reduce the biological 2 
effects of this molecule. For example, proanthocyanidins [27,28] and polyamines such as spermine 3 
[29] are both compound classes with demonstrated high-affinity binding to the lipid A moiety of 4 
LPS. In binding lipid A, these compounds hamper LPS interactions with the mammalian receptors 5 
TLR4/MD2, and thereby reduce activation of the innate immune response and septic shock. 6 
 7 
Some antimicrobial peptides are naturally produced by bacteria to overcome competition for 8 
space and nutrients [30]. They have been recognised as a promising alternative to antibiotics for 9 
overcoming AMR [31], and are considered safe for use as food preservatives [32]. The lantibiotic 10 
nisin is an antimicrobial peptide produced by Lactococcus lactis. It is a widely-used food 11 
preservative (E234) as it displays high antimicrobial activity against diverse Gram-positive bacteria 12 
[33]. The positively charged nisin binds to bacterial membranes [34] and targets pyrophosphates 13 
in the cell wall intermediates lipid II [35,36] and undecaprenyl pyrophosphate (11PP) [37]. This 14 
results in breach of the cell membrane, inhibition of cell wall synthesis and disruption of cell 15 
division and morphogenesis [38].  16 
 17 
Here we hypothesize that phosphorylation and pyrophosphorylation sites on LPS present binding 18 
epitopes for nisin. This would be in agreement with previous studies that have shown nisin to 19 
display antimicrobial activity against certain Gram-negative species [39–41]. We studied dye 20 
release from LPS-containing liposomes to assess the role of LPS as a membrane receptor and its 21 
effect on membrane stability to nisin. Direct interactions between LPS and nisin were investigated 22 
using high resolution 31P MAS solid-state NMR. We compared smooth LPS from several different 23 
Gram-negative species inhabiting different ecological niches including B. melitensis, an 24 
immunosilent pathogen, K. pneumoniae, a pulmonary pathogen and the enteric commensal E. coli, 25 
  
 7 
that have evolved alongside enteric microbiota producing antimicrobials and under immune 1 
surveillance from the host. We also tested LPS from rough chemootypes of E. coli, Rc having the 2 
outer core and Rd, in which the outer core is absent, to assess the role of phosphate exposure in 3 
mutated LPS and the protective role of the O-chain.  4 
 5 
MATERIALS AND METHODS 6 
The phospholipid 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) (Avanti Polar Lipids Inc. 7 
Alabastar, Alabama, USA) was used as purchased at > 98% purity. LPSs from rough E. coli Rd and Rc 8 
chemotypes were purchased at > 99% purity from Sigma Aldrich (Poole, UK) and used without 9 
further purification. Smooth type LPSs from K. pneumoniae ATCC 15380, S. enterica and E. coli 10 
111:B4 (smooth-type) were purchased at 40 – 60 % purity from Sigma Aldrich (Poole, UK) and 11 
purified as previously described [11]. LPS from B. melitensis was prepared in-house by phenol 12 
extraction and purified to >99% purity as described previously [42]. All other chemicals were of 13 
analytical or reagent grade. Nisin A was purified from Nisaplin (DuPont Health Bioscience ApS) to 14 
HPLC grade at >98% purity, as described previously [37,38].  15 
 16 
LPS suspension preparation  17 
Purified LPS was resuspended in HPLC grade water at 5 mg/ml, followed by incubation at 56°C for 18 
15 min, vortexing for 2 min and cooling on ice. This process was repeated a total of three times. 19 
The suspension was stored at 4°C for up to 4 h. Dry lipid was hydrated with the LPS suspensions, 20 
subjected to a further three thermal cycles and liposomes recovered from centrifugation pellet as 21 
described previously [11]. 22 
 23 
Bacterial OM isolation 24 
 8 
Cultures of E. coli BL21 were grown on Luria Bertani nutrient broth to OD of 1.2. Cells were 1 
pelleted by centrifugation at 4,500 x g, pellets were resuspended in Tris buffered saline (TBS), pH 2 
7.5 and mechanically disrupted using 36,000 psi cell in a French press. Unbroken cells and debris 3 
were removed by centrifugation at 10,000 x g and the supernatant was treated with lysozyme. 4 
OMs were collected by ultracentrifugation at 100,000 x g, the pellet obtained was resuspended in 5 
HEPES buffer pH 7.5 and separated by sucrose gradient centrifugation. 6 
 7 
Preparation of liposomes for leakage studies 8 
Dry lipid films (0.2 mg DOPC) were hydrated in 1 ml 5(6)-carboxyfluorescein (CF) (Acros organics) 9 
buffer (50 mM CF, 50 mM NaCl, 10 mM Hepes, pH 7.4), for 1 h. For DOPC lipid films requiring LPS 10 
addition, 0.2 ml of a 1 mg/ml LPS suspension was added prior to CF addition and lyophilised 11 
overnight. The solution then underwent five cycles of freeze-thawing in which it was frozen with 12 
liquid nitrogen and thawed at 40°C. The solution was extruded 11 times through a 1 m pore size 13 
polycarbonate filter using an Avanti extruder (Avanti polar lipids Inc). The excess CF was removed 14 
by gel filtration on a PD-10 column (GE Healthcare) equilibrated with 100 mM NaCl in 10 mM 15 
Hepes, pH 7.4. The CF labelled vesicles were collected, stored a 4°C, and used within 24 h.  16 
 17 
Dye release studies 18 
Pure nisin was dissolved in 100 mM NaCl, 10 mM Hepes (pH 7.4) and equilibrated overnight at 4°C. 19 
Nisin-induced CF release was monitored by measuring fluorescence increase (excitation 490 nm, 20 
emission 515 nm, 400 V) over 240 s, at which time intensity changes with time were within 1%. CF-21 
loaded large unilamellar vesicles (LUVs) in buffer (100 mM NaCl, 10 mM Hepes, pH 7.4) were 22 
equilibrated until steady background fluorescence was achieved, as described previously [43]. 23 
Nisin was added after 60 s (final concentration range of 50 – 0.75 g/ml) and after equilibration 24 
residual liposomes were dispersed with Triton X-100 (Fluka Biochemika). The procedure was 25 
  
 9 
repeated in triplicate for all vesicles at all nisin concentrations. The peptide-induced CF leakage 1 
was expressed as a fraction of CF release on Triton X-100 addition, normalised to background 2 
fluorescence: 3 
 4 
% leakge = (Fnisin – F0 )/(FTx – F0 )*100 5 
 6 
where F0 is the baseline fluorescence recorded before addition of nisin, Fnisin is the steady state 7 
fluorescence induced by nisin and FTx is the maximum fluorescence after Triton X-100 addition. 8 
 9 
Solid state NMR 10 
All experiments were performed on a Varian VNMRS400 widebore spectrometer with a 4 mm T3 11 
MAS NMR probe (Varian, Palo Alto CA, USA). Temperature was regulated using balanced 12 
heated/vortex tube-cooled gas flow [44]. All 31P MAS NMR spectra were referenced externally to 13 
10% H3PO4 at 0 ppm. Direct excitation spectra were obtained using a single 125 kHz pulse, 14 
followed by proton decoupling. Heteronuclear SPINAL-64 proton decoupling [45] of 45 kHz B1 was 15 
sufficient to remove heteronuclear interactions, as phosphates have no directly bonded protons 16 
and two-bond couplings are comparatively weak. Spectral acquisitions were repeated at 5 s 17 
interpulse delay during direct excitation experiments, which exceeds approximately five-fold the 18 
31P and 1H longitudinal relaxation times in lipids and 8192 transients were averaged in each 19 
acquisition. All experiments were acquired at 5 kHz MAS speed and 20°C, unless otherwise stated. 20 
Spectra were processed and analysed using ACD/Labs (Advanced Chemistry Development, Inc., 21 
Toronto, Canada). Spectral deconvolution was used for the quantitative analysis of spectra and 22 
cumulative pyrophosphate fractional intensity was used to estimate the molar fraction of LPS in 23 
the membranes, as previously described [34,46]. Chemical shifts were compared to spectral 24 
simulations for 1,4 phosphorylation or pyrophosphorylation of each monosaccharide, according to 25 
 10 
published values. Homogeneous broadening was assumed and resonances were approximated by 1 
fitting Gauss-Lorentzian lineshapes with 5 Hz Lorentzian broadening.  2 
 3 
RESULTS  4 
LPS modulates nisin-induced dye release 5 
The role of LPS as a receptor for nisin is reflected in the extent to which its presence in model 6 
membranes modulates nisin-induced dye release. LUVs of DOPC containing 1:1 w:w  LPS (between 7 
2 and 12% molar, depending on LPS type) were used as membrane mimics, as the zwitterionic 8 
phosphatidylcholine (PC) headgroups only show weak, non-specific interactions with nisin [34]. 9 
 10 
CF release from pure DOPC vesicles was used as negative control and compared with leakage from 11 
DOPC vesicles containing LPS from different Gram-negative species. Changes in fluorescence are 12 
reported from steady state, reached after equilibration. In all cases, the similar levels of CF release 13 
(typically monitored at 20% and 40% release) were observed from LPS-containing liposomes at 14 
lower nisin/lipid ratios compared with pure DOPC (Figure 2). This increase in leakage was 15 
chemotype and bacterial species dependent, with rough-type LPS mutants of E. coli (Rd) and (Rc) 16 
causing the highest increases in sensitivity to nisin. Dye release was bimodal with weaker dose-17 
response at low levels of nisin (typically below 20% release) followed by stronger dose-response 18 
beyond a break in trend (typically near 40% release), in which dose-response becomes parallel to 19 
that in LPS-free liposomes. Low level leakage is dominated by initial LPS recognition and leads to 20 
partial dye release, which is reflected in levelling of the response to increasing nisin concentrations 21 
after available LPS sites are occupied. This initial nisin release is enhanced significantly in the 22 
presence of LPS. The high level regimen is dominated by receptor-independent breach of the 23 
DOPC bilayer by nisin, in which DOPC/nisin interactions are responsible for membrane instability 24 
which lead to total dye release. The high levels of leakage are characterised by a faster dye release 25 
  
 11 
with a stronger response to nisin at higher concentrations (typically near and above 40% dye 1 
release) and is identifiable in all leakage curves. Within this regimen, dose-response is very similar 2 
in the absence and presence of all LPS types. 3 
 4 
To understand the role of LPS as a receptor for nisin we followed the low levels of CF release up to 5 
20 or 30%. The presence of rough chemotype LPS from E. coli enhanced membrane disruption 6 
approximately 20-fold, compared to pure DOPC vesicles (Figure 2). Smooth type LPS from K. 7 
pneumoniae also enhanced sensitivity to nisin with LPS from both species resulting in 20% CF 8 
release occurring at fivefold lower nisin concentrations than PC vesicles. LPS from E. coli, smooth 9 
chemotype, S. enterica and B. melitensis had a weaker effect on nisin-induced leakage with 3 to 2-10 
fold lower nisin/DOPC levels at 20 % CF release compared to DOPC membranes. Initial release at 11 
<10% CF leakage singles out LPS from B. melitensis, in the presence of which membrane stability 12 
was maintained better than the other LPS types. In addition to differences in the core, this 13 
difference can be rationalised when considering enhanced membrane stability in the presence of 14 
the C28-OH chain in B. melitensis LPS (Figure 1), which is absent from all other LPS chemotypes.   15 
 16 
We compared the effects that individual LPS types have on membrane susceptibility to nisin by 17 
considering dye release at different nisin/LPS molar ratios (Figure 3). While the molecular weight 18 
for rough types LPS are known, the molecular weight for the smooth LPS types were calculated 19 
from the 31P MAS NMR spectra using the fractional intensity of the pyrophosphates (cf. the NMR 20 
section below). Direct comparison of dye release in the presence of different LPSs confirmed that 21 
rough chemotypes sensitize membranes to nisin to a greater extent than smooth chemotypes and 22 
at 20% CF release, the membrane leakage was enhanced in descending order from E. coli Rd and 23 
Rc, smooth chemotype K. pneumoniae, E. coli, and S. enterica with the least impact observed in 24 
the presence of B. melitensis LPS. Compared to B. melitensis and S. enterica LPS, rough chemotype 25 
 12 
E. coli Rd and Rc LPS show 20 and 10-fold leakage enhancement respectively, followed by K. 1 
pneumoniae, and E. coli at 3 to 2-fold. At this level of dye release, the protective effect of C28-OH 2 
was overwhelmed and membranes with LPS from E. coli and S. enterica, two bacterial species that 3 
are well-adapted to antimicrobials produced by gut microbiota [47],responded in a comparable 4 
way to membranes containing LPS from B. melitensis. Similarity in the lipid A region dictates 5 
common responses to nisin for all smooth LPS chemotypes. Rough chemotypes stood out, which 6 
clearly demonstrate the protective role of the O-antigen and the outer core as observed in the 7 
different responses noted for E. coli smooth, Rd and Rc chemotypes.   8 
 9 
Molecular interactions and nisin/LPS membrane complexes – solid state NMR studies 10 
In some bacteria, the core region of LPS can be phosphorylated and/or pyrophosphorylated [4,11], 11 
which provides unique reporters for studying molecular interactions in membranes by solid state 12 
NMR [24]. We used high resolution solid state 31P MAS NMR to observe changes in the 13 
spectroscopic fingerprints of LPSs which are caused by changes in electronic environment of 14 
negatively charged phosphates following interactions with the cationic lantibiotic nisin. We 15 
consider two possibilities: a change in ionization state  from RPO4
2- to RHPO4
-, which carries a 16 
significant downfield shift of approximately -1ppm; and a redistribution of electron density in the 17 
proximity of the cationic peptide, which leads to more subtle changes in isotropic chemical shifts 18 
[48]. To understand the molecular bases of different membrane tolerances to nisin in the presence 19 
of LPS from different microorganisms, we considered B. melitensis LPS, which caused very little 20 
change, E. coli LPS, which did reduce nisin tolerance to a small extent and, K. pneumoniae smooth 21 
LPS, which enhanced most significantly membrane susceptibility to nisin. In addition, we 22 
considered rough chemotype LPS from E. coli to understand the role of O-antigen as an 23 
accessibility barrier, as well as E. coli OM extracts to bring our models to a closer approximation of 24 
the membrane environment in bacterial cells. 25 
  
 13 
 1 
Dye release showed minimal impact of smooth type LPS from B. melitensis on DOPC membrane 2 
stability. Membranes of the same composition, B. melitensis LPS/DOPC in 1:1 w/w ratio, were 3 
studied by high resolution 31P MAS NMR.  The spectrum is dominated by the DOPC phosphate 4 
resonance at -0.97ppm and no additional phosphates were observed (Figure 4a). A single, well-5 
resolved pyrophosphate resonance from the LPS is seen at -11.6ppm. The overlapping resonances 6 
from the two phosphorus signals reveal that the PP is alkylated (amino-alkylated) and not free, 7 
consistent with genomic predictions and mutant analyses [49]. Comparing the integrals of the two 8 
resonances allowed us to estimate the molar ratio at approximately 2% and Mw at 39.3 ±0.2 kDa, 9 
which was used in Figure 3. Addition of nisin lead to a small downfield shift in PP to -11.4 ppm, 10 
which we interpret as the result of changes in surface charge density, rather than a specific 11 
molecular interaction [48]. 12 
 13 
The presence of LPS from K. pneumoniae shows the highest degree of increase in membrane 14 
susceptibility to nisin. To understand better the molecular bases of this observation we 15 
investigated LPS/DOPC membranes at 1:1 w/w ratio by 31P MAS NMR (Figure 4b). DOPC molar 16 
excess yields the dominant intensity at -0.97 ppm but the phosphorylation pattern of K. 17 
penumoniae LPS is significantly different from that of B. melitensis (cf. Figure 4a). 18 
Pyrophosphorylation is evident with resonances at -6.8 and -12.2 ppm alongside well-resolved 19 
phosphate at 2.0 ppm, a phosphate 3.4 ppm (derived from spectral fitting) and phosphonate at 20 
19.6 ppm, as we previously reported [11] (Figure 4b). Integral intensities in the pyro- and 21 
monophosphates relate approximately as 1:1:1:2:1 in increasing chemical shift. The phosphonate 22 
intensity is significantly smaller, due to high mobility in the phosphorylated region. Comparison 23 
with the DOPC intensity yields an estimate for the molar fraction at 2.0% and Mw of 40.1 ±0.2 kDa 24 
for K. pneumoniae LPS. 25 
 14 
 1 
The single pyrophosphate is non-alkylated with the resonance at -10.7 ppm arising from the 2 
proximal to the saccharide phosphate at position 4 on glucose (predicted shift of -10.7 ppm) and a 3 
free distal phosphate at -6.8 ppm, which revealed a charge of -2 (predicted shift was -6.5 ppm for 4 
RPO4
2- and for charge of -1 in RHPO4
- was -8.0 ppm).  5 
 6 
Addition of nisin lead to a minor downfield shift in both pyrophosphate resonances, more 7 
pronounced in the distal, free phosphate from -6.8 to -7.1 ppm and in the proximal phosphate 8 
from -12.2 to -12.3 ppm (Figure 4b, bottom). The comparatively small change suggests charge 9 
density redistribution due to proximity of nisin [48], rather than a change in phosphate ionization 10 
state. The LPS phosphates showed a significantly stronger response, in which the 3.4 ppm 11 
resonance is no longer observable, while the major resonance at 2.0 ppm is shifted to 1.1 ppm. 12 
The resonance at 3.4 ppm corresponds to a doubly ionized 4-heptose monophosphate, while the 13 
2.01.1 ppm shift is interpreted as protonation of 1-Hep phosphate. These observations point to 14 
a binding site for nisin between the inner and outer core of K. pneumoniae LPS. 15 
 16 
The phosphonate chemical shift remained unchanged but the resonance gained intensity following 17 
nisin binding which leads to increased efficiency of proton decoupling. While not involved directly 18 
in the interaction with nisin, the phosphorylation site is close and dynamically coupled to the LPS 19 
binding site. 20 
 21 
DOPC membranes containing an equal weight of LPS from smooth chemotype E. coli were slightly 22 
more susceptible to nisin than membranes containing LPS from B. melitensis or S. enterica but 23 
more resistant than membranes containing K. penumoniae LPS (Figure 3). Solid state 31P MAS NMR 24 
spectra from E. coli smooth LPS-containing membranes showed a single site of non-alkylated 25 
  
 15 
pyrophosphorylation with proximal phosphate resonance at -10.8 ppm and distal free doubly 1 
ionized phosphate at -5.9 ppm (Figure 4c). A phosphate resonance from E. coli smooth LPS was 2 
observed at 3.2 ppm with twice the intensity of the individual phosphates in the pyrophosphates 3 
spectral features. Mean integral comparison of pyrophosphate resonances with the dominant 4 
DOPC phosphate resonance at -0.97 ppm showed LPS to be present at 2.2 molar % and an 5 
approximate Mw of 35.7 ±0.2 kDa. 6 
 7 
Addition of nisin had a profound effect on the monophosphate resonance shift, which changed by 8 
-0.9 ppm from 3.2 to 2.3 ppm. In addition, the distal phosphate resonance in the pyrophosphate 9 
was shifted by -0.3 ppm from -5.9 to -6.2 ppm. The proximal to the saccharide phosphate was only 10 
slightly shifted from -10.7 to -10.8 ppm, as it is further away from the cationic peptide and 11 
screened by electronic distribution of the distal phosphate. The large chemical shift change in the 12 
monophosphate resonance revealed its direct involvement in the binding site for nisin and a 13 
change in its protonation state following nisin binding. 14 
 15 
Since rough chemotypes lack O-chain protection such that the core region is more easily accessible 16 
to antimicrobials [8],  we investigated the role of phosphates in Rc LPS from E. coli in nisin binding 17 
by following changes in the high-resolution 31P MAS NMR spectra from Rc LPS in DOPC 18 
membranes. The pyrophosphorylation is different from that for the smooth chemotype [8], 19 
showing that the majority of pyrophosphates are not free but alkylated, as seen in the chemical 20 
shift values of -10.7 and -11.5 ppm (Figure 5a). Addition of nisin appeared to affect neither 21 
pyrophosphate shifts, nor their relative intensity, which lead us to the conclusion that the 22 
alkylated pyrophosphates do not participate in nisin binding. 23 
 24 
 16 
The Rc LPS is multiply phosphorylated as seen in resonances at 0.2 and -0.5 ppm with fractional 1 
intensities of 25 and 26%, respectively (Figure 5a). An additional resonance of 3.6% spectral 2 
contribution is resolved at -1.8 ppm. Addition of nisin attenuated slightly the resonance at -0.5 3 
ppm and more significantly the 0.1 ppm resonance from 25% to 7%. Nisin binding also revealed an 4 
additional resonance at 0.6 ppm, the intensity of which is likely to have been reduced by 5 
segmental motions in nisin-free LPS. 6 
 7 
Rough LPS phenotype d (Rd) lacks the outer core region, which contains a number of important 8 
phosphorylation and pyrophosphorylation sites  [8]. Equal fractions by weight of E. coli Rd LPS in 9 
DOPC membranes contribute little to 31P MAS NMR intensity. A free pyrophosphate is observed at 10 
-12.3 and -7.4 ppm for the proximal and distal phosphates with a contribution of 1% along with 11 
monophosphates at 1.7 and 2.6 ppm of 1% intensity each (Figure 5b). The free pyrophosphate is 12 
likely located at position 1 or 4’ on the glucosamine disaccharide of lipid A and can also be 13 
resolved in the spectra from Rc LPS in representative small contribution [8]. Addition of nisin 14 
shifted the distal pyrophosphate resonance from -7.4 to -8.1 ppm, which was accompanied by a 15 
small shift of the proximal one from -12.3 to -12.5 ppm while the relative resonance intensity 16 
remained unchanged. The monophosphate resonances coalesced into a single peak at 1.26 ppm 17 
with intensity of 2% relative to DOPC.  18 
 19 
Comparison between the 31P NMR spectra from Rc and Rd LPS (Figure 5) shows significantly 20 
greater degree of phosphorylation and pyrophosphorylation in Rc LPS compared to Rd LPS from E. 21 
coli. A direct indicator is the lipid A resonance at -12.3 ppm, present in both spectra but at very 22 
low intensity in the NMR spectrum from Rc LPS compared to pyrophosphates form the outer core. 23 
This is a significant observation, which reveals the outer core of LPS as the primary site for 24 
  
 17 
phosphorylation and pyrophosphorylation rather than lipid A and points to the key contribution of 1 
the outer core to divalent cation coordination and as the LPS layer stability mediator.      2 
 3 
To bridge our model studies with the effect of nisin on bacterial envelopes in situ we investigated 4 
OM extracts from E. coli BL21 using 31P solid state MAS NMR (Figure 6). This strain has rough type 5 
LPS lacking the O-antigen and its 31P NMR spectroscopic features compare with those from Rc LPS 6 
(Figure 5a). Significant pyrophosphorylation is evident with species giving rise to major resonances 7 
at -10.8 and -12.9 ppm with relative intensity of 29 and 6%, respectively. The resonances are 8 
significantly broader in these primarily composed of LPS membranes than in the LPS/DOPC 9 
membranes, where collective effects are removed by electrostatic repulsion between LPS 10 
molecules (Figure 4c). A monophosphate resonance is seen at 3.3 ppm (Figure 6) corresponds to 11 
the 3.2 ppm resonance in LPS from smooth chemotype E. coli (cf. Figure 4c). Addition of nisin lead 12 
to comparatively small changes in the pyrophosphate region, where the -12.3 ppm resonance was 13 
shifted to -12.9 ppm without any marked change in relative intensity between the two peaks. 14 
However, as in the smooth type LPS chemotype, the upfield phosphate resonance at 3.3 ppm was 15 
suppressed entirely or shifted downfield to merge with another resonance at final shift of 1.6 ppm 16 
(Figure 6). 17 
 18 
DISCUSSION  19 
Nisin acts against Gram-positive bacteria through binding pyrophosphates on bacterial cell wall 20 
precursors lipid II and 11PP [35,37] to form pores in the cell membrane, disrupting the membrane 21 
and inhibiting cell wall synthesis [36]. Although in Gram-negative bacteria the peptidoglycan 22 
precursors are protected by the OM, previous work has revealed phosphorylation and 23 
pyrophosphylation of LPS [8,11], which together with divalent cations are essential for OM 24 
stability, (Nikaido 2003)[1] [4] but can also serve as receptors on the bacterial surfaces. Such 25 
 18 
receptor binding sites can be utilised by antimicrobial proteins and peptides for destabilising and 1 
traversing the OM, as we have shown to occur during the action of colicin N (Johnson, Ridley et al. 2 
2014)[2] [8], which was also corroborated by the reported activity of nisin against Gram-negative 3 
bacteria treated with metal ion chelators [50]. Here, we observed for the first time that LPS can 4 
form molecular complexes with nisin which can destabilise membranes and that such complexes 5 
form in model membranes, as well as in bacterial OM extracts. The degree, to which LPS mediates 6 
membrane disruption by nisin is influenced by the bacterial origin of the LPS and is related to the 7 
ecological life style of the bacterial species. 8 
 9 
Activation of host TLR4-mediated responses by LPS shows species variation with commensal 10 
microorganisms displaying weaker receptor binding than pathogenic species [21], a trait which 11 
enables them to form part of the normal microbiota. Species variation is also seen with the 12 
receptor-independent interactions between LPS and lipid rafts where LPS from E. coli binds with 13 
lower affinity to membranes than LPS from typically pathogenic species [24]. We investigated 14 
species variation in LPS-mediated response to nisin that correlates with habitation of different 15 
ecological niches. For example, lantibiotic producers are resident members of the gastrointestinal 16 
tract microbiota [51–54] and commensal Gram-negative bacteria evolving under selective 17 
pressure in their presence show reduced LPS/nisin interactions. By contrast, non-enteric 18 
pathogens that have not experienced long-term exposure to antimicrobials have LPS that confers 19 
stronger and more disruptive interactions with nisin. In the case of B. melitensis, a pathogen that 20 
evolved an intracellular lifestyle and characteristically multiplies in professional and non-21 
professional phagocytes [55], LPS adaptations confer indifference to nisin as well as concealing 22 
binding sites otherwise used for recognition by antimicrobial peptides and TLR4-MD2 receptor 23 
complexes [15,42,56]. 24 
 25 
  
 19 
Dye release from liposomes showed that LPS from B. melitensis had little impact on the ability of 1 
nisin to disrupt membranes. The presence of C28 acylation in lipid A is a likely contributor to 2 
increased membrane stability and tolerance to nisin. Furthermore, the adaptations in B. melitensis 3 
LPS to life within a challenging ecological niche would also require low receptor binding site 4 
presentation. This was confirmed by solid state NMR, which did not show any measurable spectral 5 
changes in the presence of nisin. We did not observe the 3.2 ppm monophosphate resonances 6 
observed for deacylated core oligosaccharide [15], as most likely these monophosphates only 7 
remain after cleavage of pyrophosphates during harsh deacylation prior to solution NMR studies. 8 
Instead, we observe pyrophosphorylation, which also appears to be capped by either alkylation or 9 
with ethanolamine, which makes negative charges less accessible and can explain the more 10 
pronounced resistance of B. melitensis to antimicrobials. In fact, it has been shown recently that B. 11 
melitensis carries a lipid A phosphoethanolamine transferase gene (lptA) associated with 12 
resistance to polymyxin B and lipid A pyrophosphoethanolamine substitutions [49] (see also 13 
below).   14 
 15 
 16 
LPS from the gut commensal E. coli and from the enteropathogenic S. enterica does sensitize 17 
liposomes to a slightly greater extent, which is consistent with the evolution of these organisms 18 
within the gut in a competitive environment containing natural producers of lantibiotics and other 19 
antimicrobials. Compared to B. melitensis, such reduction in membrane stability is likely to be 20 
augmented by the lack of C28 acylation in enterobacterial LPS. Significant phosphorylation is 21 
evident in the 31P MAS NMR spectra from E. coli LPS, which presents binding sites for targeting by 22 
cationic antimicrobials. Indeed, major chemical shift changes confirm the existence of molecular 23 
complexes between nisin and smooth chemotype LPS from E. coli. Target engagement does not 24 
appear to involve directly free pyrophosphates but is mainly associated with monophosphorylated 25 
 20 
LPS sites, suggesting the additional role of saccharides in receptor binding sites, as seen in lipid II 1 
recognition by nisin [57]. Extending the model from isolated LPS to OM extracts confirms the 2 
recognition of monophosphorylated saccharides during nisin binding to LPS.    3 
 4 
The presence in liposomes of LPS from K. pneumoniae significantly increased their susceptibility to 5 
nisin in comparison to LPS from Salmonella and E. coli. As in these enteric bacteria, Klebsiella LPS 6 
lacks the C28 chain, which indicates that the enhanced susceptibility results from additional 7 
epitopes in the core region. Besides 1,4’ lipid A phosphorylation sites [58], phosphorylation in the 8 
core region is significant and monophosphates are directly involved in the nisin binding epitope. In 9 
addition to changes in chemical shifts of monophosphates in the presence of nisin, the 31P MAS 10 
NMR spectra reveal changes in dynamics in the vicinity on sugar phosphates, which suggests 11 
anchoring of the nisin/LPS complex to the membrane or the formation of a higher oligomeric 12 
state. The observed higher affinity for nisin compared to E. coli and S. enterica is likely the result of 13 
the reduced ability of K. pneumoniae to adapt to lantibiotic pressure in contrast to its adaptation 14 
to cationic peptides using colistin as a probe in the primary pulmonary niche [58]. While acyl chain 15 
hydroxylation under colistin pressure in murine lung infection models increases tolerance in K. 16 
pneumoniae [58], our results reveal a primary binding site location in the outer core of LPS such 17 
that acyl chain hydroxylation is unlikely to affect nisin/LPS interactions. Such adaptive differences 18 
reflect major differences in the molecular mechanisms of nisin and colistin and emphasize the 19 
complexity of microbial interactions in the host. 20 
 21 
The absence of O-antigen in rough bacterial phenotypes results in LPS presenting nisin-binding 22 
sites located near the membrane surface. Solid state NMR indicates reduced population of these 23 
phosphorylation sites compared to phosphorylation in the outer core. Nonetheless, easier 24 
accessibility of these sites near the membrane markedly enhances membrane disruption by nisin. 25 
  
 21 
We conclude that extensive decoy phosphorylation in the outer core underpin the protective role 1 
of LPS and resistance to antimicrobials. In agreement with this result, it has previously been shown 2 
that deletions in the core oligosaccharide lead to increased nisin sensitivity in Salmonella 3 
typhimurium [40].   4 
 5 
Our results corroborate this and show that LPS from K. pneumoniae acts as an enhancer of nisin-6 
induced membrane damage.  It is unclear whether K. pneumoniae can adapt under longer term 7 
lantibiotic pressure in oxygen-rich environments via LpxO-mediated hydroxylation of lipid A, as 8 
observed with colistin [58,59]. 9 
 10 
The lowest levels of nisin sensitivity are seen with E. coli, S. enterica and B. melitensis. E. coli is a 11 
commensal bacterium which forms part of the gastrointestinal tract microbiota [60], and a low 12 
response to nisin is possibly an evolutionary adaptation based on ecological niche. Although 13 
Salmonella is an enteric pathogen, there are reports of S. enterica residing in the gastrointestinal 14 
tract in individuals who display asymptomatic carriage [61–63]. Since S. enterica can be recognised 15 
as a non-pathogenic resident of the gastrointestinal tract, the reduced sensitivity to nisin may also 16 
be due an evolutionary adaptation based on ecological niche. An alternative explanation is that 17 
the reduced nisin binding affinity of S. enterica LPS may be a protective mechanism for virulence. 18 
Salmonella has known antimicrobial-peptide evasion mechanisms involving structural alterations 19 
to LPS [23,64,65]. It is possible that a similar mechanism to the lipid A modification regulated by 20 
PhoPQ  exists (Reference?) which protects the pathogen from the effects of nisin. 21 
 22 
The reduced nisin sensitivity of B. melitensis is unusual. It has previously been shown that Brucella 23 
LPS is pyrophosphorylated [11] and therefore should provide a binding site for nisin. However, 24 
Brucella displays weak TLR4 recognition and resistance to antimicrobial peptides of the innate 25 
 22 
immune response [6,66,67]. The lipid A moiety differs from the canonical lipid A (Figure 1) and, 1 
atypically, B. melitensis possesses a core oligosaccharide containing a large number of positively 2 
charged amino groups [15,56]. In this lipid A, KDO1 links lipid A to the O-antigen through a glucose 3 
unit, whilst KDO1 is linked to mannose and four glucosamine units, creating a structure that 4 
protrudes laterally, concealing the negatively charges groups essential for interaction with LPS 5 
binding proteins, CD14 and TLR4, thus evading innate immune recognition [15]. It is likely that this 6 
unusual LPS structure also provides protection against nisin. In addition to capping pyrophosphate, 7 
positive charges carried by hexosamines within the core oligosaccharide may prevent positively 8 
charged nisin from binding these concealed pyrophosphates  [42,56]. 9 
 10 
The present findings show for the first time the existence of lantibiotic targets on the exterior of 11 
Gram-negative OM suggesting that lantibiotics may be used in the management of Gram-negative 12 
infections and in the control of Gram-negative food related bacteria. Phosphates in LPS within 13 
OMs are often involved in cation-mediated molecular bridges and adjuvant use of divalent cation 14 
chelators e.g. EDTA is recommended to increase their availability as nisin recognition sites. 15 
Phosphate recognition and competition with divalent cations also explains enhanced susceptibility 16 
to nisin observed in chelator-treated E. coli [50]. The importance of these results is enhanced by 17 
the very low frequency of resistance to nisin and the extracellular presentation of phosphates and 18 
pyrophosphates as natural receptor binding sites. Surface presentation of these chemical moieties 19 
is unique to bacteria and their function cannot be substituted by simple mutations, although 20 
further research will be required to investigate whether target modification mechanisms exist 21 
which can affect the action of lantibiotics. Using lantibiotics alone or as adjuvants in the control 22 
Gram-negative bacteria is an exciting possibility in the increasing prevalence in resistance to 23 
antibiotics. 24 
 25 
  
 23 
Conclusions 1 
The OM protects Gram-negative bacteria from environmental hazards, such as antimicrobial 2 
peptides. Structural stability in the outer leaflet is provided by via an electrostatic network 3 
involving phosphates and pyrophosphates on LPS bridged by divalent cations. Besides providing a 4 
protective layer and defining the chemical identity of bacteria the LPS layer presents targets for 5 
recognition by antimicrobial peptides. We investigate the role of LPS as a mediator of nisin-6 
induced membrane damage and conclude that LPS can serve as a “receptor” for nisin and as a 7 
facilitator of nisin-induced membrane disruption. LPS from rough phenotypes, particularly the 8 
shorter type d, presents binding sites near the membrane surface that are readily used by nisin to 9 
destabilize the membrane. The presence of outer core and O-antigen in LPS from smooth bacterial 10 
chemotypes reveals significant phosphorylation and pyrophosphorylation, which offers decoy 11 
targets and enhances membrane resistance to antimicrobial disruption. LPS from pathogenic K. 12 
pneumoniae sensitizes membranes more than LPS from gut commensal E. coli that follows a 13 
lifestyle challenged by antimicrobials [68]. LPS from B. melitensis, which has evolved for a life of 14 
stealth and which has in its lipid A a long C28-OH chain, capable of traversing both membrane 15 
leaflets, has only marginal impact on membrane susceptibility to nisin. Molecular complexes 16 
readily form between nisin and LPS from pathogenic K. pneumoniae, as well as from gut 17 
commensal E. coli. The primary LPS epitope for nisin binding involves saccharide monophosphates 18 
rather than pyrophosphates that comprise the primary nisin epitopes in peptidoglycan 19 
intermediates [37]. The monophosphate targeted by nisin in smooth chemotype LPS derived from 20 
E. coli and reconstituted in model membranes is also targeted by nisin in E. coli outer membrane 21 
extracts. LPS from B. melitensis does not show any monophosphorylation but has an alkylated 22 
pyrophposphorylate. We saw no evidence of nisin binding, which confirms our conclusion that B. 23 
melitensis OM are silent and inherently resistant to nisin. We also conclude that pyrophosphate 24 
 24 
alkylation confers additional protection against cationic antimicrobials without affecting surface 1 
charge density essential to OM stability. 2 
 3 
Acknowledgements 4 
The work was funded by the Biotechnology and Biological Sciences Research Council Catalyst grant 5 
BB/N010426/1. AG is co-funded by the Medical Research Council grant MR/N010477/1. AL was 6 
funded by the Wellcome Trust Antimicrobial Resistance Doctoral Training Programme 7 
(108876/Z/15/Z). CP is a BBSRC Industrial CASE Doctoral Fellow co-sponsored by DuPont 8 
Bioscience ASP, who also provided Nisaplin. Research at the Department of Microbiology and 9 
Parasitology of the University of Navarra is supported by the Institute for Tropical Health funders 10 
(Obra Social la CAIXA, Fundaciones Caja Navarra and Roviralta, PROFAND, Ubesol, ACUNSA and 11 
Artai) and by MINECO grant AGL2014-58795-CA.  12 
 13 
  14 
  
 25 
REFERENCES 1 
[1] J. O ’neill, Tackling Drug-Resistant Infections Globally: Final Report and Recommendations 2 
the Review on Antimicrobial Resistance, (2016). 3 
[2] S. Harbarth, G. Kahlmeter, J. Kluytmans, M. Mendelson, G.S. Hospital, C. Town, S. Africa, C. 4 
Pulcini, N. Singh, U. Theuretzbacher, C.U.S. Food, S. Spring, L. Grayson, C. Houchens, D.L. 5 
Monnet, M. Ouellette, J.B. Patel, N. Zealand, E. Carrara, A. Savoldi, D. Kattula, F. Burkert, 6 
Global priority list of antibiotic-resistant bacteria to guide research, discovery, and 7 
development of new antibiotics, (2017). 8 
[3] M.G. Gänzle, C. Hertel, W.P. Hammes, Resistance of Escherichia coli and Salmonella against 9 
nisin and curvacin A, Int. J. Food Microbiol. 48 (1999) 37–50. doi:10.1016/S0168-10 
1605(99)00026-4. 11 
[4] H. Nikaido, Molecular basis of bacterial outer membrane permeability revisited., Microbiol. 12 
Mol. Biol. Rev. 67 (2003) 593–656. doi:10.1128/MMBR.67.4.593. 13 
[5] N. Ruiz, D. Kahne, T.J. Silhavy, Advances in understanding bacterial outer-membrane 14 
biogenesis., Nat. Rev. Microbiol. 4 (2006) 57–66. doi:10.1038/nrmicro1322. 15 
[6] G.M. De Tejada, E. Moreno, I. Moriyón, The outer membranes of Brucella spp . are resistant 16 
to bactericidal cationic peptides . These include : The Outer Membranes of Brucella spp . 17 
Are Resistant to Bactericidal Cationic Peptides, Microbiology. 63 (1995) 3054–3061. 18 
[7] C.R. Raetz, C.M. Reynolds, M.S. Trent, R.E. Bishop, Lipid A modification systems in Gram-19 
negative bacteria, Annu. Rev. Biochem. (2007) 295–329. 20 
doi:10.1146/annurev.biochem.76.010307.145803.LIPID. 21 
[8] C.L. Johnson, H. Ridley, R. Marchetti, A. Silipo, D.C. Griffin, L. Crawford, B. Bonev, A. 22 
Molinaro, J.H. Lakey, The antibacterial toxin colicin N binds to the inner core of 23 
lipopolysaccharide and close to its translocator protein, Mol. Microbiol. 92 (2014) 440–452. 24 
doi:10.1111/mmi.12568. 25 
[9] E. Moreno, S.E. Stackebrandt, M. Dorsch, J. Wolters, M. Busch, H. Mayer, Brucella abortus 26 
16S rRNA and Lipid A Reveal a Phylogenetic Relationship with Members of the Alpha-2 27 
Subdivision of the Class Proteobacteria, J. Bacteriol. 172 (1990) 3569–3576. 28 
[10] O. Holst, Chemical Structure of the Core Reegion of Lipopolysachharides., 1999. 29 
[11] F. Ciesielski, D.C. Griffin, M. Rittig, I. Moriyón, B.B. Bonev, Interactions of lipopolysaccharide 30 
with lipid membranes, raft models - A solid state NMR study, Biochim. Biophys. Acta - 31 
Biomembr. 1828 (2013) 1731–1742. doi:10.1016/j.bbamem.2013.03.029. 32 
[12] C.R. Raetz, C. Whitfield, Lipopolysaccharide endotoxins, Annu. Rev. Biochem. 71 (2002) 33 
635–700. doi:10.1146/annurev.biochem.71.110601.135414. 34 
[13] I. Lerouge, J. Vanderleyden, O-antigen structural variation : mechanisms and possible roles 35 
in animal / plant ^ microbe interactions, FEMS Microbiol. Rev. 26 (2001) 17–47. 36 
[14] J. Kubler-Kielb, E. Vinogradov, W.I. Ng, B. MacZynska, A. Junka, M. Bartoszewicz, A. Zelazny, 37 
J. Bennett, R. Schneerson, The capsular polysaccharide and lipopolysaccharide structures of 38 
two carbapenem resistant Klebsiella pneumoniae outbreak isolates, Carbohydr. Res. 369 39 
(2013) 6–9. doi:10.1016/j.carres.2012.12.018. 40 
[15] C. Fontana, R. Conde-álvarez, J. Ståhle, O. Holst, M. Iriarte, Y. Zhao, V. Arce-gorvel, S. 41 
Hanniffy, J. Gorvel, I. Moriyón, G. Widmalm, Structural Studies of Lipopolysaccharide-42 
defective Mutants from Brucella melitensis Identify a Core Oligosaccharide Critical in 43 
Virulence *, J. Biol. Chem. 291 (2016) 7727–7741. doi:10.1074/jbc.M115.701540. 44 
[16] J. Kubler-Kielb, E. Vinogradov, The study of the core part and non-repeating elements of the 45 
O-antigen of Brucella lipopolysaccharide, Carbohydr. Res. 76 (2013) 33–37. 46 
doi:10.1007/s11103-011-9767-z.Plastid. 47 
[17] E.L. Wu, O. Engstro, S. Jo, D. Stuhlsatz, M.S. Yeom, J.B. Klauda, G. Widmalm, W. Im, 48 
 26 
Molecular Dynamics and NMR Spectroscopy Studies of E . coli Lipopolysaccharide Structure 1 
and Dynamics, 105 (2013) 1444–1455. doi:10.1016/j.bpj.2013.08.002. 2 
[18] A. Poltorak, X. He, I. Smirnova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, 3 
C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, B. Beutler, Defective LPS 4 
Signalling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in TLR4 gene, Science (80-. ). 282 5 
(1998) 2085–2088. 6 
[19] S. Akira, Mammalian Toll-like receptors, Curr. Opin. Immunol. 15 (2003) 5–11. 7 
doi:10.1016/S0952-7915(02)00013-4. 8 
[20] J. Da Silva Correia, K. Soldau, U. Christen, P.S. Tobias, R.J. Ulevitch, Lipopolysaccharide is in 9 
close proximity to each of the proteins in its membrane receptor complex. Transfer from 10 
CD14 to TLR4 and MD-2, J. Biol. Chem. 276 (2001) 21129–21135. 11 
doi:10.1074/jbc.M009164200. 12 
[21] S.I. Miller, R.K. Ernst, M.W. Bader, LPS, TLR4 and infectious disease diversity, Nat Rev 13 
Microbiol. 3 (2005) 36–46. doi:nrmicro1068 [pii]\r10.1038/nrmicro1068. 14 
[22] E. Barquero-Calvo, R. Conde-Alvarez, C. Chacon-Diaz, L. Quesada-Lobo, A. Martirosyan, C. 15 
Guzman-Verri, M. Iriarte, M. Mancek-Keber, R. Jerala, J.P. Gorvel, I. Moriyon, E. Moreno, E. 16 
Chaves-Olarte, The differential interaction of Brucella and Ochrobactrum with innate 17 
immunity reveals traits related to the evolution of stealthy pathogens, PLoS One. 4 (2009) 18 
e5893. doi:10.1371/journal.pone.0005893. 19 
[23] L. Guo, K.B. Lim, J.S. Gunn, B. Bainbridge, R.P. Darveau, M. Hackett, S.L. Miller, Regulation of 20 
Lipid A Modifications by Salmonella typhimurium Virulence genes phoP-phoQ, Science (80-. 21 
). 276 (1997) 250–253. 22 
[24] F. Ciesielski, B. Davis, M. Rittig, B.B. Bonev, P. O’Shea, Receptor-independent interaction of 23 
bacterial lipopolysaccharide with lipid and lymphocyte membranes; the role of cholesterol, 24 
PLoS One. 7 (2012) e38677. doi:10.1371/journal.pone.0038677. 25 
[25] J. Mares, S. Kumaran, M. Gobbo, O. Zerbe, Interactions of Lipopolysaccharide and Polymyxin 26 
Studied by NMR spectroscopy, J. Biol. Chem. 284 (2009) 11498–11506. 27 
doi:10.1074/jbc.M806587200. 28 
[26] Y.J. Oh, B. Plochberger, M. Rechberger, P. Hinterdorfer, Characterizing the effect of 29 
polymyxin B antibiotics to lipopolysaccharide on Escherichia coli surface using atomic force 30 
microscopy, (2017) 1–7. doi:10.1002/jmr.2605. 31 
[27] J.B. Delehanty, B.J. Johnson, T.E. Hickey, T. Pons, F.S. Ligler, Binding and Neutralization of 32 
Lipopolysaccharides by Plant Proanthocyanidins, (2007) 1718–1724. 33 
[28] B.J. Johnson, J.B. Delehanty, B. Lin, F.S. Ligler, Immobilized Proanthocyanidins for the 34 
Capture of Bacterial Lipopolysaccharides, 80 (2008) 17112–17116. 35 
[29] S.J. Wood, K.A. Miller, G.H. Lushington, M.R. Burns, S.A. David, Anti-Endotoxin Agents . 3 . 36 
Rapid Identification of High-Affinity Lipopolysaccharide-Binding Compounds in a Substituted 37 
Polyamine Library, (2006) 27–36. 38 
[30] S.C. Yang, C.H. Lin, C.T. Sung, J.Y. Fang, Antibacterial activities of bacteriocins: Application in 39 
foods and pharmaceuticals, Front. Microbiol. 5 (2014) 1–15. doi:10.3389/fmicb.2014.00241. 40 
[31] J. Dale-Skinner, B. Bonev, Molecular Mechanisms ofAntibiotic Resistance: The Need for 41 
Novel Antimicrobial Therapies, 2008. 42 
[32] L.H. Deegan, P.D. Cotter, C. Hill, P. Ross, Bacteriocins: Biological tools for bio-preservation 43 
and shelf-life extension, Int. Dairy J. 16 (2006) 1058–1071. 44 
doi:10.1016/j.idairyj.2005.10.026. 45 
[33] J. Delves-Broughton, Applications of the bacteriocin, nisin, Antonie van Leeuwenhoek, Int. J. 46 
Gen. Mol. Microbiol. 69 (1996) 193–202. doi:10.1007/BF00399424. 47 
[34] B.B. Bonev, W.C. Chan, B.W. Bycroft, G.C.K. Roberts, A. Watts, Interaction of the lantibiotic 48 
nisin with mixed lipid bilayers: A P-31 and H-2 NMR study, Biochemistry. 39 (2000) 11425–49 
  
 27 
11433. doi:10.1021/bi0001170. 1 
[35] E. Breukink, I. Wiedemann, C. van Kraaij, O.P. Kuipers, H.-G. Sahl, B. de Kruijff, Use of the 2 
Cell Wall Precursor Lipid II by a Pore-Forming Peptide Antibiotic, Science (80-. ). 286 (1999) 3 
2361–4. doi:10.1126/science.286.5448.2361. 4 
[36] I. Wiedemann, E. Breukink, C. Van Kraaij, O.P. Kuipers, G. Bierbaum, B. De Kruijff, H.G. Sahl, 5 
Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and 6 
inhibition of cell wall biosynthesis for potent antibiotic activity, J. Biol. Chem. 276 (2001) 7 
1772–1779. doi:10.1074/jbc.M006770200. 8 
[37] B.B. Bonev, E. Breukink, E. Swiezewska, B. De Kruijff, A. Watts, Targeting extracellular 9 
pyrophosphates underpins the high selectivity of nisin, FASEB J. 18 (2004). 10 
doi:10.1096/fj.04-2358com. 11 
[38] A.J. Hyde, J. Parisot, A. McNichol, B.B. Bonev, Nisin-induced changes in Bacillus morphology 12 
suggest a paradigm of antibiotic action., Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 19896–13 
901. doi:10.1073/pnas.0608373104. 14 
[39] A.M.S. Carneiro De Melo, G.M. Cook, R.J. Miles, R.K. Poole, Nisin stimulates oxygen 15 
consumption by Staphylococcus aureus and Escherichia coli, Appl. Environ. Microbiol. 62 16 
(1996) 1831–1834. 17 
[40] K.A. Stevens, N.A. Klapes, B.W. Sheldon, T.R. Klaenhammer, Antimicrobial action of nisin 18 
against Salmonella typhimurium lipopolysaccharide mutants, Appl. Environ. Microbiol. 58 19 
(1992) 1786–1788. 20 
[41] K.A. Stevens, B.W. Sheldon, N.A. Klapes, T.R. Klaenhammer, Nisin treatment for inactivation 21 
of Salmonella species and other gram- negative bacteria, Appl. Environ. Microbiol. 57 (1991) 22 
3613–3615. doi:0099-2240/91/123613-03$02.00/0. 23 
[42] J. Velasco, J.A. Bengoechea, K. Brandenburg, B. Lindner, U. Seydel, D. González, U. 24 
Zähringer, E. Moreno, I. Moriyón, Brucella abortus and its closest phylogenetic relative, 25 
Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance, 26 
Infect. Immun. 68 (2000) 3210–3218. doi:10.1128/IAI.68.6.3210-3218.2000. 27 
[43] J. Parisot, S. Carey, E. Breukink, W.C. Chan, A. Narbad, B. Bonev, Molecular mechanism of 28 
target recognition by subtilin, a class I lanthionine antibiotic, Antimicrob. Agents 29 
Chemother. 52 (2008) 612–618. doi:10.1128/AAC.00836-07. 30 
[44] F. Ciesielski, D.C. Griffin, M. Rittig, B.B. Bonev, High-resolution J-coupled 13C MAS NMR 31 
spectroscopy of lipid membranes, Chem. Phys. Lipids. 161 (2009) 77–85. 32 
doi:10.1016/j.chemphyslip.2009.07.001. 33 
[45] B.M. Fung, A.K. Khitrin, K. Ermolaev, An improved broadband decoupling sequence for 34 
liquid crystals and solids, J. Magn. Reson. 142 (2000) 97–101. doi:Doi 35 
10.1006/Jmre.1999.1896. 36 
[46] B.B. Bonev, Y.H. Lam, G. Anderluh, A. Watts, R.S. Norton, F. Separovict, Effects of the 37 
eukaryotic pore-forming cytolysin equinatoxin II on lipid membranes and the role of 38 
sphingomyelin, Biophys. J. 84 (2003) 2382–2392. doi:10.1016/S0006-3495(03)75044-9. 39 
[47] W.K. Mousa, B. Athar, N.J. Merwin, N.A. Magarvey, Antibiotics and specialized metabolites 40 
from the human microbiota, Nat. Prod. Rep. 34 (2017) 1302–1331. 41 
doi:10.1039/C7NP00021A. 42 
[48] B. Bonev, A. Watts, G. Gro, Electrostatic peptide – lipid interactions of amyloid- b peptide 43 
and pentalysine with membrane surfaces monitored by 31 P MAS NMR, (2001). 44 
doi:10.1039/b103352m. 45 
[49] R. Conde-Álvarez, L. Palacios-Chaves, Y. Gil-Ramírez, M. Salvador-Bescós, M. Bárcena-46 
Varela, B. Aragón-Aranda, E. Martínez-Gómez, A. Zúñiga-Ripa, M.J. de Miguel, T.L. 47 
Bartholomew, S. Hanniffy, M.-J. Grilló, M.Á. Vences-Guzmán, J.A. Bengoechea, V. Arce-48 
Gorvel, J.-P. Gorvel, I. Moriyón, M. Iriarte, Identification of lptA, lpxE, and lpxO, Three Genes 49 
 28 
Involved in the Remodeling of Brucella Cell Envelope, Front. Microbiol. 8 (2018) 2657. 1 
doi:10.3389/fmicb.2017.02657. 2 
[50] J.K. Branen, P.M. Davidson, Enhancement of nisin, lysozyme, and monolaurin antimicrobial 3 
activities by ethylenediaminetetraacetic acid and lactoferrin, Int. J. Food Microbiol. 90 4 
(2004) 63–74. doi:10.1016/S0168-1605(03)00172-7. 5 
[51] A. Bolotin, P. Wincker, S. Mauger, O. Jaillon, K. Malarme, J. Weissenbach, S.D. Ehrlich, A. 6 
Sorokin, The Complete Genome Sequence of the Lactic Acid Bacterium, Genome Res. (2001) 7 
731–753. doi:10.1101/gr.169701.There. 8 
[52] L.A. David, C.F. Maurice, R.N. Carmody, D.B. Gootenberg, J.E. Button, B.E. Wolfe, A. V. Ling, 9 
A.S. Devlin, Y. Varma, M.A. Fischbach, S.B. Biddinger, R.J. Dutton, P.J. Turnbaugh, Diet 10 
rapidly and reproducibly alters the human gut microbiome, Nature. 505 (2013) 559–563. 11 
doi:10.1038/nature12820. 12 
[53] N. Klijn, A.H. Weerkamp, W.M. De Vos, N. Klijn, A.H. Weerkamp, Genetic marking of 13 
Lactococcus lactis shows its survival in the human gastrointestinal tract . These include : 14 
Genetic Marking of Lactococcus lactis Shows Its Survival in the Human Gastrointestinal 15 
Tract, 61 (1995) 2771–2774. 16 
[54] P. Veiga, N. Pons, A. Agrawal, R. Oozeer, D. Guyonnet, R. Brazeilles, J.-M. Faurie, J.E.T. van 17 
Hylckama Vlieg, L.A. Houghton, P.J. Whorwell, S.D. Ehrlich, S.P. Kennedy, Changes of the 18 
human gut microbiome induced by a fermented milk product, Sci. Rep. 4 (2015) 6328. 19 
doi:10.1038/srep06328. 20 
[55] E. Barquero-Calvo, E. Chaves-Olarte, D.S. Weiss, C. Guzmán-Verri, C. Chacón-Díaz, A. 21 
Rucavado, I. Moriyón, E. Moreno, Brucella abortus uses a stealthy strategy to avoid 22 
activation of the innate immune system during the onset of infection, PLoS One. 2 (2007). 23 
doi:10.1371/journal.pone.0000631. 24 
[56] R. Conde-Alvarez, V. Arce-gorvel, M. Iriarte, M. Mancek-Keber, E. Barquero-Calvo, L. 25 
Palacios-Chaves, C. Chacon-Diaz, E. Chaves-Olarte, A. Martirosyan, K. von Bergen, M.-J. 26 
Grillo, R. Jerala, K. Brandenburg, E. Llobert, J.A. Bengoechea, E. Moreno, I. Moriyon, J.-P. 27 
Gorvel, The Lipopolysaccharide Core of Brucella abortus Acts as a Shield Against Innate 28 
Immunity Recognition, PLOS Pathog. 8 (2012) e1002675. doi:10.1371/journal.ppat.1002675. 29 
[57] S. Mulholland, E.R. Turpin, B.B. Bonev, J.D. Hirst, Docking and molecular dynamics 30 
simulations of the ternary complex nisin 2 :lipid II, (2016). doi:10.1038/srep21185. 31 
[58] E. Llobet, V. Martínez-Moliner, D. Moranta, K.M. Dahlström, V. Regueiro, A. Tomás, V. Cano, 32 
C. Pérez-Gutiérrez, C.G. Frank, H. Fernández-Carrasco, J.L. Insua, T.A. Salminen, J. 33 
Garmendia, J.A. Bengoechea, Deciphering tissue-induced Klebsiella pneumoniae lipid A 34 
structure, Proc. Natl. Acad. Sci. 112 (2015) E6369–E6378. doi:10.1073/pnas.1508820112. 35 
[59] A. Mularski, J. Wilksch, E. Hanssen, J. Li, T. Tomita, S.J. Pidot, T. Stinear, F. Separovic, D. 36 
Strugnell, A nanomechanical study of the effects of colistin on the Klebsiella pneumoniae 37 
AJ218 capsule, Eur. Biophys. J. 46 (2017) 351–361. doi:10.1007/s00249-016-1178-2. 38 
[60] O. Tenaillon, D. Skurnik, B. Picard, E. Denamur, The population genetics of commensal 39 
Escherichia coli, Nat.Rev.Microbiol. 8 (2010) 207–217. doi:10.1038/nrmicro2298. 40 
[61] J. Dekker, K. Frank, Salmonella, Shigella and Yersinia, Clin. Labortary Med. 35 (2015) 225–41 
246. doi:10.1037/emo0000122.Do. 42 
[62] S. Devi, C.J. Murray, Salmonella carriage rate amongst school children--a three year study., 43 
Southeast Asian J. Trop. Med. Public Health. 22 (1991) 357–361. 44 
[63] M.B. Zaidi, J.J. Calva, M.T. Estrada-Garcia, V. Leon, G. Vazquez, G. Figueroa, E. Lopez, J. 45 
Contreras, J. Abbott, S. Zhao, P. McDermott, L. Tollefson, Integrated food chain surveillance 46 
system for Salmonella spp. in Mexico, Emerg. Infect. Dis. 14 (2008) 429–435. 47 
doi:10.3201/eid1403.071057. 48 
[64] R.K. Ernst, T. Guina, S.I. Miller, Salmonella typhimurium outer membrane remodeling : role 49 
  
 29 
in resistance to host innate immunity, (2001) 1327–1334. 1 
[65] W.W. Navarre, T.A. Halsey, D. Walthers, J. Frye, M. McClelland, J.L. Potter, L.J. Kenney, J.S. 2 
Gunn, F.C. Fang, S.J. Libby, Co-regulation of Salmonella enterica genes required for virulence 3 
and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ, Mol. Microbiol. 56 (2005) 4 
492–508. doi:10.1111/j.1365-2958.2005.04553.x. 5 
[66] N. Lapaque, I. Moriyon, E. Moreno, J.-P. Gorvel, Brucella lipopolysaccharide acts as a 6 
virulence factor, Curr. Opin. Microbiol. 8 (2005) 60–66. 7 
[67] G. Tumurkhuu, N. Koide, K. Takahashi, F. Hassan, S. Islam, H. Ito, I. Mori, T. Yoshida, T. 8 
Yokochi, Characterization of biological activities of Brucella melitensis lipopolysaccharide, 9 
Microbiol Immunol. 50 (2006) 421–427. doi:JST.JSTAGE/mandi/50.421 [pii]. 10 
[68] N.H. Salzman, K. Hung, D. Haribhai, H. Chu, J. Karlsson-Sjöberg, E. Amir, P. Teggatz, M. 11 
Barman, M. Hayward, D. Eastwood, M. Stoel, Y. Zhou, E. Sodergren, G.M. Weinstock, C.L. 12 
Bevins, C.B. Williams, N.A. Bos, Enteric defensins are essential regulators of intestinal 13 
microbial ecology, Nat. Immunol. 11 (2010) 76–83. doi:10.1038/ni.1825. 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 30 
OH
O
O
NH
NH
O
OH
O
O
NH
NH
OH
CH3
O
OH
CH3
O
OH
O
O
O
O
O
O P O
O
O
-
P
O O
-
CH3
CH3
CH3
CH3
OH
NH3
+
 1 
 2 
 3 
 4 
 5 
   6 
 7 
 8 
 9 
 10 
 11 
Figure 1: Structure and variations in bacterial LPSs:   12 
A The structure of Lipid A in Enterobacteriaceae (left) and Brucella (right) (only the major chemical 13 
species are presented); non-canonical structures are shown in lavender. B Structure of the core 14 
oligosaccharides in E. coli, K. pneumoniae and B. melitensis.  15 
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Figure 2: Nisin-mediated CF leakage  2 
Nisin/lipid dependence of nisin-induced CF release from DOPC unilamellar vesicles alone (squares) 3 
or in the presence of 1:1 weight fraction of smooth-type LPS from E. coli (circles), S. enterica (aqua 4 
triangles), K. pneumoniae (green triangles) or B. melitensis (diamonds); or rough type c (Rc, purple) 5 
or, d (Rd, orange) from E. coli. Error bars show variance within the triplicate.  6 
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Figure 3: Dependence on LPS type of nisin-induced CF release: smooth-type LPS from E. coli 2 
(circles), S. enterica (aqua triangles), K. pneumoniae (green triangles), B. melitensis (diamonds) or, 3 
rough type c (Rc, purple) or d (Rd, orange) from E. coli. Error bars show variance within the 4 
triplicate. 5 
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Figure 4: Direct excitation solid state 31P MAS NMR spectra from DOPC MLV suspensions 3 
containing LPS from B. melitensis (A), K. pneumoniae (B) and E. coli smooth chemotype (C) without 4 
(top spectra) and with nisin (bottom spectra). Measurable shifts are highlighted. 5 
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Figure 5: Direct excitation solid state 31P MAS NMR spectra from DOPC MLV suspensions 4 
containing LPS from E. coli rough chemotype c (A) and d (B) without (top spectra) and with nisin 5 
(bottom spectra). Measurable shifts and attenuated resonances are highlighted. 6 
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Figure 6: Direct excitation solid state 31P MAS NMR spectra from E. coli BL21 outer membrane 4 
extracts without (top) and with nisin (bottom). Measurable shifts and attenuated resonances are 5 
highlighted. Red line shows total spectral intensity after deconvolution. 6 
 7 
 8 
 9 
 10 
 11 
 12 
